CHINA PHARMA HOLDINGS, INC. Basic Shares Outstanding (Weighted Average)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Basic Shares Outstanding (Weighted Average) of 40.52 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 40.52M shares, a 1156.05% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 25.60M shares, a 684.88% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 6.76M shares, a 193.01% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.87M shares, a 123.85% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 4.29M shares, a 145.73% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.75M shares, a 48.39% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 3.38M shares, a 221.82% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.05M shares, a 77.21% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 40.52M shares 10-Q · filed 2026-08-14 | 34.09M shares 10-Q · filed 2026-08-14 | 24.30M shares derived: average of 3 quarters · filed 2026-08-14 | 19.19M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 25.60M shares 10-Q · filed 2026-05-15 | 16.18M shares derived: average of 2 quarters · filed 2026-05-15 | 12.08M shares derived: average of 3 quarters · filed 2026-05-15 | 9.87M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 6.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 5.32M shares derived: average of 2 quarters · filed 2026-04-01 | 4.62M shares derived: average of 3 quarters · filed 2026-08-14 | 4.29M shares 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | 3.87M shares 10-Q · filed 2025-11-12 | 3.55M shares derived: average of 2 quarters · filed 2026-08-14 | 3.47M shares 10-Q · filed 2025-11-12 | 3.17M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 3.23M shares 10-Q · filed 2026-08-14 | 3.26M shares 10-Q · filed 2025-08-14 | 3.26M shares 10-Q · filed 2026-08-14 | 3.26M shares 10-Q · filed 2025-08-14 | 2.93M shares derived: average of 3 quarters · filed 2026-08-14 | 2.63M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 3.26M shares 10-Q · filed 2026-05-15 | 2.78M shares derived: average of 2 quarters · filed 2026-05-15 | 2.43M shares derived: average of 3 quarters · filed 2026-05-15 | 2.23M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 2.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 2.02M shares derived: average of 2 quarters · filed 2026-04-01 | 1.88M shares derived: average of 3 quarters · filed 2026-04-01 | 1.75M shares 10-K · filed 2026-04-01 | 17.46M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 1.73M shares 10-Q · filed 2025-11-12 | 17.31M shares 10-Q · filed 2024-11-13 | 1.67M shares derived: average of 2 quarters · filed 2025-11-12 | 1.56M shares 10-Q · filed 2025-11-12 | 15.59M shares 10-Q · filed 2024-11-13 | 2.99M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 1.61M shares 10-Q · filed 2025-08-14 | 16.12M shares 10-Q · filed 2024-08-14 | 1.47M shares 10-Q · filed 2025-08-14 | 14.73M shares 10-Q · filed 2024-08-14 | 3.41M shares derived: average of 3 quarters · filed 2025-08-14 | 3.22M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 1.33M shares 10-Q · filed 2025-05-14 | 4.31M shares derived: average of 2 quarters · filed 2025-05-14 | 3.75M shares derived: average of 3 quarters · filed 2025-05-14 | 3.24M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 7.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 4.96M shares derived: average of 2 quarters · filed 2025-03-31 | 3.87M shares derived: average of 3 quarters · filed 2025-03-31 | 3.38M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 2.64M shares 10-Q · filed 2024-11-13 | 13.22M shares 10-Q · filed 2023-11-13 | 2.17M shares derived: average of 2 quarters · filed 2024-11-13 | 2.08M shares 10-Q · filed 2024-11-13 | 10.42M shares 10-Q · filed 2023-11-13 | 506.52K shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 1.69M shares 10-Q · filed 2024-08-14 | 9.92M shares 10-Q · filed 2023-08-14 | 1.65M shares 10-Q · filed 2024-08-14 | 9.00M shares 10-Q · filed 2023-08-14 | -205.73K shares derived: average of 3 quarters · filed 2024-08-14 | 1.10M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 8.08M shares 10-Q · filed 2023-05-12 | -1.15M shares derived: average of 2 quarters · filed 2024-04-01 | 898.56K shares derived: average of 3 quarters · filed 2024-04-01 | 1.89M shares derived: average of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | -10.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -2.69M shares derived: average of 2 quarters · filed 2024-04-01 | -178.08K shares derived: average of 3 quarters · filed 2024-04-01 | 1.05M shares 10-K · filed 2024-04-01 | 5.26M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 5.00M shares 10-Q · filed 2023-11-13 | 50.02M shares 10-Q · filed 2022-11-14 | 4.93M shares derived: average of 2 quarters · filed 2023-11-13 | 4.86M shares 10-Q · filed 2023-11-13 | 48.63M shares 10-Q · filed 2022-11-14 | -25.92M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 4.85M shares 10-Q · filed 2023-08-14 | 48.49M shares 10-Q · filed 2022-08-11 | 4.79M shares 10-Q · filed 2023-08-14 | 47.93M shares 10-Q · filed 2022-08-11 | -36.23M shares derived: average of 3 quarters · filed 2023-08-14 | -15.68M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 4.74M shares 10-Q · filed 2023-05-12 | 47.37M shares 10-Q · filed 2022-05-12 | -56.78M shares derived: average of 2 quarters · filed 2023-05-12 | -22.52M shares derived: average of 3 quarters · filed 2023-05-12 | -5.49M shares derived: average of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -118.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -36.14M shares derived: average of 2 quarters · filed 2023-03-30 | -8.90M shares derived: average of 3 quarters · filed 2023-03-30 | 4.61M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 46.00M shares 10-Q · filed 2022-11-14 | 45.79M shares derived: average of 2 quarters · filed 2022-11-14 | 45.58M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 45.58M shares 10-Q · filed 2022-08-11 | 45.58M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 45.58M shares 10-Q · filed 2022-05-12 | |||||||
| 2016-09-30 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2016-06-30 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares derived: average of 3 quarters · filed 2016-08-11 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2016-03-31 | 43.58M shares 10-Q · filed 2016-05-16 | 43.58M shares derived: average of 2 quarters · filed 2016-05-16 | 43.58M shares derived: average of 3 quarters · filed 2016-11-14 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2015-12-31 | 43.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares derived: average of 3 quarters · filed 2016-11-14 | 43.58M shares 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | 43.58M shares 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | 43.58M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |